Figures & data
Figure 1 Number of enrolled patients.
![Figure 1 Number of enrolled patients.](/cms/asset/fad7e2e0-fda0-4c7f-9cab-a55bf70d37a3/dndt_a_27025_f0001_b.jpg)
Table 1 Included studies
Figure 2 HDRS-24 % decrease in patients treated with ECT, rTMS, and deepTMS from baseline to the fourth week of treatment.
![Figure 2 HDRS-24 % decrease in patients treated with ECT, rTMS, and deepTMS from baseline to the fourth week of treatment.](/cms/asset/17ebe85c-8189-42fa-9eb9-f049e6fa8d4d/dndt_a_27025_f0002_b.jpg)
Figure 3 HDRS-24 % decrease in patients treated with ECT and deepTMS after 2 and 4 weeks of treatment.
![Figure 3 HDRS-24 % decrease in patients treated with ECT and deepTMS after 2 and 4 weeks of treatment.](/cms/asset/8bb0b3fb-da8f-48df-b356-1bf8947c9827/dndt_a_27025_f0003_b.jpg)
Figure 4 Cognitive variations in patients treated with ECT and rTMS from T0 to T1 (2 weeks of treatment).
![Figure 4 Cognitive variations in patients treated with ECT and rTMS from T0 to T1 (2 weeks of treatment).](/cms/asset/06a7c8e1-b93c-42f2-8212-07b9d4f016a2/dndt_a_27025_f0004_b.jpg)
Figure 5 Cognitive variations in patients treated with ECT and rTMS from T0 to T2 (4 weeks of treatment).
![Figure 5 Cognitive variations in patients treated with ECT and rTMS from T0 to T2 (4 weeks of treatment).](/cms/asset/a1a88512-9e68-498f-a9b3-8d0d137768bd/dndt_a_27025_f0005_b.jpg)
Figure 6 Percentage of remitted patients.
![Figure 6 Percentage of remitted patients.](/cms/asset/42b74293-4428-4136-99e8-dbda302c99e9/dndt_a_27025_f0006_b.jpg)
Figure 7 Percentage of dropped-out patients.
![Figure 7 Percentage of dropped-out patients.](/cms/asset/e2a427fd-0d44-4c15-86ab-4b4c2804c582/dndt_a_27025_f0007_b.jpg)